These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30635235)

  • 21. [IV Consensus Meeting of the Spanish Society of Liver Transplantation 2012. Exceptions to model for end-stage liver disease in prioritizing liver transplantation].
    Lladó L; Bustamante J;
    Gastroenterol Hepatol; 2014 Feb; 37(2):83-91. PubMed ID: 24290253
    [No Abstract]   [Full Text] [Related]  

  • 22. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation.
    Santoyo J; Suarez MA; Fernandez-Aguilar JL; Perez Daga JA; Sanchez-Perez B; Ramirez C; Aranda JM; Rodríguez-Canete A; Gonzalez-Sanchez A
    Transplant Proc; 2006 Oct; 38(8):2462-4. PubMed ID: 17097967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma in two patients with cardiac cirrhosis.
    Saliba T; Dorkhom S; O'Reilly EM; Ludwig E; Gansukh B; Abou-Alfa GK
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):889-91. PubMed ID: 19550346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Liver transplantation organ allocation between Child and MELD.
    Graziadei I
    Wien Med Wochenschr; 2006 Jul; 156(13-14):410-5. PubMed ID: 16937044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Liver transplantation].
    Frei P; Geier A; Dutkowski P; Müllhaupt B
    Ther Umsch; 2011 Apr; 68(4):219-24. PubMed ID: 21452144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolated heart transplant and combined heart-liver transplant in adult congenital heart disease patients: Insights from the united network of organ sharing.
    Bradley EA; Pinyoluksana KO; Moore-Clingenpeel M; Miao Y; Daniels C
    Int J Cardiol; 2017 Feb; 228():790-795. PubMed ID: 27888756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
    Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
    Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival.
    Ioannou GN; Perkins JD; Carithers RL
    Gastroenterology; 2008 May; 134(5):1342-51. PubMed ID: 18471511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characteristics of waitlisted patients for liver transplantation at a liver transplantation unit in the city of Ribeirão Preto, São Paulo, Brazil, especially considering Child and Model for End Stage Liver Disease (MELD) scores.
    Teixeira AC; Souza FF; Sankarankutty AK; Martinelli AL; Castro E Silva O
    Transplant Proc; 2007 Mar; 39(2):387-9. PubMed ID: 17362738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. THE USE OF MELD SCORE (MODEL FOR END-STAGE LIVER DISEASE) AND DERIVATIVES IN CARDIAC TRANSPLANTATION.
    Moraes ACO; Fonseca-Neto OCLD
    Arq Bras Cir Dig; 2018; 31(2):e1370. PubMed ID: 29972398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From Child-Pugh to Model for End-Stage Liver Disease: Deciding Who Needs a Liver Transplant.
    Reddy SS; Civan JM
    Med Clin North Am; 2016 May; 100(3):449-64. PubMed ID: 27095638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatocellular carcinoma: impact of waiting list and pre-operative treatment strategies on survival of cadaveric liver transplantation in pre-MELD era in one center in Brazil].
    Freitas AC; Parolin MB; Stadnik L; Coelho JC
    Arq Gastroenterol; 2007; 44(3):189-94. PubMed ID: 18060269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical value of the model for end-stage liver disease score in predicting the prognosis of liver transplantation in patients with end-stage liver disease].
    Sun J; Guo ZH; Lai TS; Tang YQ; Su L; Huo F; Wang SP; Pu MS; Wen Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1731-2, 1742. PubMed ID: 18819907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
    Taniguchi M
    Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Liver Transplant-Related Survival Benefit in Patients With Versus Without Hepatocellular Carcinoma in the United States.
    Berry K; Ioannou GN
    Gastroenterology; 2015 Sep; 149(3):669-80; quiz e15-6. PubMed ID: 26021233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Viral Hepatitis: Knowledge and Treatments for Hepatitis B and C Virus and Associated Transplantation and Neoplasia.
    Sherman KE; Shah VH
    Gastroenterology; 2018 Feb; 154(3):453-456. PubMed ID: 29154778
    [No Abstract]   [Full Text] [Related]  

  • 39. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of model for end stage liver disease (MELD)-based systems as prognostic index for hepatocellular carcinoma.
    Limquiaco JL; Wong GL; Wong VW; Lai PB; Chan HL
    J Gastroenterol Hepatol; 2009 Jan; 24(1):63-9. PubMed ID: 19054256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.